Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Thoracic Surgery
ASCO Journal Club
Journal Club Q&A done in partnership with ASCO the Journal of Clinical Oncology
Questions discussed in this category
Is there any role for ctDNA testing after surgery or SBRT for Stage IB NSCLC to determine the need for adjuvant chemotherapy?
1 Answer available
2597
Papers discussed in this category
JCO Precision Oncology, 2017 Sep 29
Circulating Tumor DNA in Non–Small-Cell Lung Cancer: A Primer for the Clinician
Nature, 2017-04-26
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Cancer discovery, 2017-12
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.
Related Topics in Thoracic Surgery
Thoracic Malignancies
Radiation Oncology
Medical Oncology
Non-small cell lung cancer
Lung Cancer
NCI-CCC Tumor Board Question
Pulmonology
Ohio State University
Pleural Effusion
Pleural Disease